Colorectal cancer risk reduction following macrogol exposure: a cohort and nested case control study in the UK.
Animal studies have demonstrated macrogol laxatives may reduce colorectal cancer (CRC) risk. This study aimed to investigate the association between macrogol prescribing and CRC risk.A case-control study nested within a cohort of laxative users was conducted using data from the UK General Practice R...
Main Authors: | Rachel A Charlton, Julia M Snowball, Katherine Bloomfield, Corinne S de Vries |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3869778?pdf=render |
Similar Items
-
Substantiation of an approach to determination of ketoprofen and macrogol 400 esters
by: Elena Bezuglaya, et al.
Published: (2021-06-01) -
Macrogol in preparation for rontgenological and endoscopic examination of large intestine
by: I. M. Paschenko, et al.
Published: (2017-06-01) -
Intestinal preparations for colonoscopy. Comparative study: mannitol, picosulphate and macrogol
by: Abel Botelho Quaresma, et al.
Published: (2018-04-01) -
Evaluating the hazard of foetal death following H1N1 influenza vaccination; a population based cohort study in the UK GPRD.
by: Cormac J Sammon, et al.
Published: (2012-12-01) -
Functional constipation at a young age. Place of macrogol 4000 (Forlax) in the treatment
by: A.E. Dorofeiev, et al.
Published: (2019-02-01)